title: Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.
abstract: Genetic susceptibility to multiple sclerosis (MS) is associated with the MHC located on chromosome 6p21. This signal maps primarily to a 1-Mb region encompassing the HLA class II loci, and it segregates often with the HLA-DQB1*0602, -DQA1*0102, -DRB1*1501, -DRB5*0101 haplotype. However, the identification of the true predisposing gene or genes within the susceptibility haplotype has been handicapped by the strong linkage disequilibrium across the locus. African Americans have greater MHC haplotypic diversity and distinct patterns of linkage disequilibrium, which make this population particularly informative for fine mapping efforts. The purpose of this study was to establish the telomeric boundary of the HLA class II region affecting susceptibility to MS by assessing genetic association with the neighboring HLA-DRB5 gene as well as seven telomeric single nucleotide polymorphisms in a large, well-characterized African American dataset. Rare DRB5*null individuals were previously described in African populations. Although significant associations with both HLA-DRB1 and HLA-DRB5 loci were present, HLA-DRB1*1503 was associated with MS in the absence of HLA-DRB5, providing evidence for HLA-DRB1 as the primary susceptibility gene. Interestingly, the HLA-DRB5*null subjects appear to be at increased risk for developing secondary progressive MS. Thus, HLA-DRB5 attenuates MS severity, a finding consistent with HLA-DRB5's proposed role as a modifier in experimental autoimmune encephalomyelitis. Additionally, conditional haplotype analysis revealed a susceptibility signal at the class III AGER locus independent of DRB1. The data underscore the power of the African American MS dataset to identify disease genes by association in a region of high linkage disequilibrium.
authors.affiliation: Department of Neurology, University of California, San Francisco, CA 94143, USA.
authors.forename: Stacy J
authors.initials: SJ
authors.lastname: Caillier
authors.forename: Farren
authors.initials: F
authors.lastname: Briggs
authors.forename: Bruce A C
authors.initials: BA
authors.lastname: Cree
authors.forename: Sergio E
authors.initials: SE
authors.lastname: Baranzini
authors.forename: Marcelo
authors.initials: M
authors.lastname: Fernandez-Viña
authors.forename: Patricia P
authors.initials: PP
authors.lastname: Ramsay
authors.forename: Omar
authors.initials: O
authors.lastname: Khan
authors.forename: Walter
authors.initials: W
authors.lastname: Royal
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Hauser
authors.forename: Lisa F
authors.initials: LF
authors.lastname: Barcellos
authors.forename: Jorge R
authors.initials: JR
authors.lastname: Oksenberg
mesh_terms: D000328:Adult; D001741:Black or African American / Q000235:genetics*; D000818:Animals; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics* / Q000276:immunology; D030541:Databases, Genetic; D004681:Encephalomyelitis, Autoimmune, Experimental; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006684:HLA-DR Antigens / Q000235:genetics* / Q000276:immunology; D059811:HLA-DRB1 Chains; D059847:HLA-DRB5 Chains; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000276:immunology; D006801:Humans; D015810:Linkage Disequilibrium / Q000235:genetics / Q000276:immunology; D008297:Male; D009103:Multiple Sclerosis / Q000235:genetics* / Q000276:immunology; D040641:Quantitative Trait Loci / Q000235:genetics* / Q000276:immunology
chemical_list: D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D059847:HLA-DRB5 Chains; D000949:Histocompatibility Antigens Class II